InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001415889-23-007200 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-05-03 2023-05-01 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx — +41.0K 41.0K +241,029% —
D 2023-05-03 2023-05-02 TDOC Raman-Tangella Vidya Chief MEDICAL Off S - Sale+OE $26.76 -15.4K 25.6K -38% -$411.4K
D 2023-05-03 2023-05-01 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx $0.00 -41.0K 82.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-05-01 M A 40,975 — 40,992 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2023-05-02 S D 15,372 $26.76 25,620 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2023-05-01 M D 40,975 $0.00 81,952 D — · — to — 40,975 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.